1236031-63-2Relevant academic research and scientific papers
Rational Design and Integrative Assembly of Heteromeric Metalla[2]Catenanes Featuring Cp*Ir/Rh Fragments
Liu, Dong,Lu, Ye,Lin, Yue-Jian,Jin, Guo-Xin
supporting information, (2022/02/22)
We report a design strategy for integrative assembly of heteromeric [2]catenanes. The design focuses on the shape and functional group match of two different metalla-rectangles. A series of dipyridyl ligands with different lengths, widths and functional groups were designed and used for assembly experiments. Six heteromeric [2]catenanes were obtained both by direct mixture of two pre-assembled metalla-rectangles and one-pot three-component self-assembly. Multiple analytic methods were employed to characterize the catenanes, including single crystal X-ray diffraction analysis, NMR spectroscopy, mass spectroscopy and elemental analysis.
Organic compound and electrochromic element
-
Paragraph 0124-0127, (2021/06/22)
The disclosure provides an organic compound and an electrochromic element. The organic compound absorbs light of a wavelength range from 450 nm to 580 nm in a reduction state and is colored, is superior in high-temperature drive durability and is expressed by the following formula [1]. Z1 and Z2 each represent a substituent. R11 to R18 each represent a hydrogen atom or a substituent. R12 and R13 are optionally bound to each other to form a ring. R21 and R22 each represent a hydrogen atom or a substituent. X- represents an anion, and n is an integer greater than or equal to 1. When n is 2 or greater, two or more X-s are the same or different from each other.
FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE
-
Page/Page column 171, (2010/08/08)
The invention relates to thiazole compounds of Formula (I) and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
Thiazole compounds and methods of use
-
Page/Page column 33, (2008/06/13)
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
